These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The biological relevance of N-terminal neurotensin fragments in the regulation of exocrine pancreas secretion. Nustede R; Köhler H; Pfannkuche A; Fölsch UR; Schafmayer A Pancreas; 1989; 4(1):114-9. PubMed ID: 2717600 [TBL] [Abstract][Full Text] [Related]
6. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039 [TBL] [Abstract][Full Text] [Related]
7. Effect of neurotensin and neurotensin fragments on gastric acid secretion in man. Holst Pedersen J; Skov Olsen P; Kirkegaard P Regul Pept; 1986 Aug; 15(1):77-86. PubMed ID: 3763961 [TBL] [Abstract][Full Text] [Related]
8. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma. Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of neurotensin by isolated perfused rat kidney. Gillatt DJ; Shulkes A; Read DM; Hardy KJ Am J Physiol; 1990 Jun; 258(6 Pt 1):E930-6. PubMed ID: 2360626 [TBL] [Abstract][Full Text] [Related]
10. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography. Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977 [TBL] [Abstract][Full Text] [Related]
11. The stability and metabolism of intravenously administered neurotensin in the rat. Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE Peptides; 1982; 3(4):637-42. PubMed ID: 7134032 [TBL] [Abstract][Full Text] [Related]
12. Intact neurotensin (NT) in human plasma: response to oral feeding. Shaw C; Buchanan KD Regul Pept; 1983 Oct; 7(2):145-53. PubMed ID: 6197723 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and biological activity of kinetensin in conscious sheep. Read D; Shulkes A; Fletcher D; Hardy K Agents Actions; 1993 Mar; 38(3-4):231-9. PubMed ID: 8213349 [TBL] [Abstract][Full Text] [Related]
14. Expression of neurotensin in endocrine tumors. Kapuscinski M; Shulkes A; Read D; Hardy KJ J Clin Endocrinol Metab; 1990 Jan; 70(1):100-6. PubMed ID: 2403568 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism. Holst Pedersen J; Fahrenkrug J Peptides; 1986; 7(1):15-20. PubMed ID: 3714532 [TBL] [Abstract][Full Text] [Related]
17. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion. Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043 [TBL] [Abstract][Full Text] [Related]
18. Neuromedin-N is not released with neurotensin from rat ileum. Cuber JC; Herrmann C; Kitabgi P; Bosshard A; Bernard C; De Nadai F; Chayvialle JA Endocrinology; 1990 Mar; 126(3):1584-92. PubMed ID: 2307120 [TBL] [Abstract][Full Text] [Related]